Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NSC 4810 是一种酰胺类生物活性化合物,它在体内已被用作细胞色素P450酶的底物,在体外被用作乙酰胆碱酯酶的底物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 575 | 现货 | ||
25 mg | ¥ 1,945 | 现货 | ||
50 mg | ¥ 2,920 | 现货 |
产品描述 | NSC 4810 is an amide bioactive compound that has been used as a substrate for cytochrome P450 enzymes in vivo and as a substrate for acetylcholinesterase in vitro. |
体内活性 | PKG drug G1 induces vasodilation of isolated resistance blood vessels and blood pressure lowering in a mouse model of angiotensin II–induced hypertension. PKG drug G1 efficiently relaxes WT but not knockin (KI) vessels, which is then assessed in a murine model of hypertension. PKG drug G1 lowers blood pressure in hypertensive WT, but not KI, mice in vivo. PKG drug G1 is tested in vivo in healthy mice implanted with telemetric devices that allow blood pressure and heart rate to be constantly monitored. PKG drug G1 or vehicle control is administrated by intraperitoneal injection, and the acute impact on hemodynamics assessed. PKG drug G1 administered at 7.4 mg/kg does not decrease blood pressure, but there is a concomitant reflex tachycardia. When this is repeated using 14.8 mg/kg dose of PKG drug G1, again blood pressure is not altered-but this higher dose induces a potentiated increase in heart rate[1]. |
分子量 | 239.74 |
分子式 | C13H18ClNO |
CAS No. | 79606-45-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (114.7 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.1712 mL | 20.8559 mL | 41.7119 mL | 104.2796 mL |
5 mM | 0.8342 mL | 4.1712 mL | 8.3424 mL | 20.8559 mL | |
10 mM | 0.4171 mL | 2.0856 mL | 4.1712 mL | 10.428 mL | |
20 mM | 0.2086 mL | 1.0428 mL | 2.0856 mL | 5.214 mL | |
50 mM | 0.0834 mL | 0.4171 mL | 0.8342 mL | 2.0856 mL | |
100 mM | 0.0417 mL | 0.2086 mL | 0.4171 mL | 1.0428 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NSC 4810 79606-45-4 Others NSC4810 NSC-4810 Inhibitor inhibitor inhibit